Filing Flows › SeaStar Medical Holding (ICU) › R&D spending
SeaStar Medical Holding (ICU) R&D spending by quarter
SeaStar Medical Holding's R&D spending was $2.5M in Q2 2026 (second quarter 2026), +8% from Q1 2026. Over the last 7 quarters it ranged from $1.0M (Q2 2025) to $2.7M (Q4 2024).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $2.5M | +8% | +143% |
| Q1 2026 | $2.3M | +7% | -4% |
| Q4 2025 | $2.2M | +19% | -20% |
| Q3 2025 | $1.9M | +78% | — |
| Q2 2025 | $1.0M | -57% | — |
| Q1 2025 | $2.4M | -11% | — |
| Q4 2024 | $2.7M | — | — |
Q2 2026 at a glance
SeaStar Medical Holding, Q2 2026: revenue $615K (+82% year over year), operating margin -616.4%, net loss $3.7M, operating cash flow −$3.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is SeaStar Medical Holding's R&D spending?
SeaStar Medical Holding's R&D spending was $2.5M in Q2 2026 (second quarter 2026), +8% from Q1 2026.
How has SeaStar Medical Holding's R&D spending changed?
Over the last 7 quarters it ranged from $1.0M (Q2 2025) to $2.7M (Q4 2024).
Q2 2026 results → · How SeaStar Medical Holding makes money →